USSTOCK.TODAY
Market Closed
Log in Sign up

Cytosorbents achieves positive operating cash flow in Q3 2026

The Motley Fool +1 · ·by G4L

CTSO
CTSO Cytosorbents Corp
$5.37 +0.56%
View chart & analysis →
  1. 1Cytosorbents recorded a positive operating cash flow of $43,000 in Q3, excluding restructuring costs.
  2. 2Cytosorbents achieved revenue of $9.7 million in Q3.
  3. 3Cytosorbents recorded an 11% decrease in operating expenses compared to the previous year.

So what's the key point?

Cytosorbents generated $9.7 million in revenue while reducing costs. This means the actual cash flow turned positive when excluding restructuring expenses.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

NextPlat shifts revenue mix toward high-margin healthcare services The Motley Fool +1 · 32m agoWidePoint Corporation Reports 27% Q3 Revenue Increase and Submits DHS Amendment Proposal The Motley Fool +1 · 32m agoFluent records $53.6 million in Q3 revenue as commerce media growth accelerates The Motley Fool +1 · 32m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news